Stryker Corporation (NYSE:SYK)‘s stock had its “hold” rating reiterated by stock analysts at Needham & Company LLC in a report released on Friday, November 3rd.
A number of other research firms have also recently weighed in on SYK. Royal Bank Of Canada reaffirmed a “buy” rating and set a $155.00 price target on shares of Stryker Corporation in a report on Monday, October 2nd. BidaskClub upgraded Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. SunTrust Banks, Inc. reiterated a “buy” rating and set a $161.00 target price on shares of Stryker Corporation in a report on Monday, October 2nd. Cowen and Company reissued a “buy” rating and issued a $160.00 price target (up previously from $150.00) on shares of Stryker Corporation in a research note on Sunday, July 30th. Finally, Oppenheimer Holdings, Inc. set a $156.00 target price on Stryker Corporation and gave the company a “hold” rating in a research report on Monday, October 30th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and fourteen have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $152.10.
Shares of Stryker Corporation (NYSE:SYK) traded down $0.94 during mid-day trading on Friday, reaching $154.79. The company’s stock had a trading volume of 874,393 shares, compared to its average volume of 1,175,304. The firm has a market cap of $57,930.00, a price-to-earnings ratio of 24.52, a PEG ratio of 2.44 and a beta of 0.79. The company has a quick ratio of 1.61, a current ratio of 2.37 and a debt-to-equity ratio of 0.63. Stryker Corporation has a one year low of $110.00 and a one year high of $160.62.
COPYRIGHT VIOLATION NOTICE: This piece was originally posted by BBNS and is the property of of BBNS. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://baseballnewssource.com/markets/stryker-corporation-syk-given-hold-rating-at-needham-company-llc/1756237.html.
In related news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $155.34, for a total transaction of $776,700.00. Following the sale, the insider now owns 83,207 shares of the company’s stock, valued at $12,925,375.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 7.40% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. increased its holdings in Stryker Corporation by 2.8% during the second quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock valued at $3,341,643,000 after buying an additional 657,656 shares during the last quarter. BlackRock Inc. increased its stake in shares of Stryker Corporation by 5.2% in the second quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock worth $3,208,017,000 after purchasing an additional 1,139,082 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Stryker Corporation by 0.5% in the first quarter. Wellington Management Group LLP now owns 4,569,118 shares of the medical technology company’s stock worth $601,525,000 after purchasing an additional 24,139 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Stryker Corporation by 6.3% in the first quarter. Geode Capital Management LLC now owns 2,786,406 shares of the medical technology company’s stock worth $366,255,000 after purchasing an additional 166,133 shares in the last quarter. Finally, Jensen Investment Management Inc. increased its stake in shares of Stryker Corporation by 11.3% in the third quarter. Jensen Investment Management Inc. now owns 2,472,476 shares of the medical technology company’s stock worth $351,141,000 after purchasing an additional 251,685 shares in the last quarter. 74.20% of the stock is owned by institutional investors and hedge funds.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with our FREE daily email newsletter.